Effect of first-line biologic initiation on glucocorticoid exposure in children hospitalized with new-onset systemic juvenile idiopathic arthritis: emulation of a pragmatic trial using observational data

Variation in treatment of children hospitalized with new‐onset systemic juvenile idiopathic arthritis in the United States

(2020) Rosemary G. Peterson et al.   ARTHRITIS CARE & RESEARCH

Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis

(2019) Benedetta Saccomanno et al.   JOURNAL OF RHEUMATOLOGY

Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study

(2019) Nienke M. ter Haar et al.   Arthritis & Rheumatology

Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis

(2018) Hatice Ezgi Baris et al.   CLINICAL RHEUMATOLOGY

Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus

(2018) Alberto Martini et al.   JOURNAL OF RHEUMATOLOGY

The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening

(2017) Xabier García-Albéniz et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans

(2017) Yukiko Kimura et al.   Pediatric Rheumatology

Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.

(2016) Miguel A. Hernán et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Effectiveness of Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years

(2016) Xabier García-Albéniz et al.   ANNALS OF INTERNAL MEDICINE

Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses

(2016) Miguel A. Hernán et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among C

(2015) Sarah Ringold et al.   ARTHRITIS AND RHEUMATISM

Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study

(2013) Sebastiaan J. Vastert et al.   Arthritis & Rheumatology

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

(2012) Nicolino Ruperto et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

(2012) Fabrizio De Benedetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO

(2012) K. Minden et al.   RHEUMATOLOGY

Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis

(2011) Marieke H. Otten et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Observational data for comparative effectiveness research: An emulation of randomised trials of statins and primary prevention of coronary heart disease

(2011) Goodarz Danaei et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series

(2010) Peter A. Nigrovic et al.   ARTHRITIS AND RHEUMATISM

Observational Studies Analyzed Like Randomized Experiments

(2008) Miguel A. Hernán et al.   EPIDEMIOLOGY